Immune responses to tumor antigens were reported to be lower in patients with NASH than in those with viral HCC,17 and the presence of CD8‐positive regulatory T cells, which are frequently expressed in NASH, was considered the main reason for this phenomenon.18 Here, CD8A is linked to metabolic dysfunction-associated steatohepatitis.